Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD) Meeting Abstract


Authors: Smith, M. R.; Sandhu, S. K.; George, D. J.; Chi, K. N.; Saad, F.; Thiery-Vuillemin, A.; Stahl, O.; Olmos, D.; Danila, D.; Gafanov, R.; Castro, E.; Moon, H.; Joshua, A. M.; Mason, G. E.; Espina, B. M.; Liu, Y.; Bevans, K. B.; Lopez-Gitlitz, A.; Francis, P.; Fizazi, K.
Abstract Title: Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S632
End Page: S633
Language: English
ACCESSION: WOS:000700527701046
DOI: 10.1016/j.annonc.2021.08.1095
PROVIDER: wos
Notes: Meeting Abstract: 582P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daniel C Danila
    154 Danila